As countries around the world race to increase COVID-19 vaccination rates within their populations, there are reports of fully immunized individuals experiencing breakthrough infections, particularly in the US and UK. A breakthrough ...
Aug 24, 2021
0
151
The availability of vaccines provides a promising solution to contain the COVID-19 pandemic. However, it remains unclear whether the large-scale vaccination can succeed in containing the COVID-19 pandemic and how soon. According ...
Aug 10, 2021
0
6
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
Jul 9, 2021
0
4
Vaccines such as Pfizer, Moderna, Johnson & Johnson and AstraZeneca are designed to prevent severe Coronavirus-19 Disease (COVID-19) due to acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and are highly efficacious. ...
Jul 7, 2021
0
2
When people say that we won't reach "herd immunity" to COVID-19, they are usually referring to an ideal of "full" population immunity: when so many people are immune that, most of the time, there is no community transmission.
Jun 14, 2021
0
2
New modeling, developed by Burnet Institute, highlights the need to preserve public health measures as a key line of defense against COVID-19 even with high vaccination coverage. It estimates more than 4800 Victorians could ...
Jun 11, 2021
0
5
American biotech company Moderna said Thursday it was asking the US Food and Drug Administration for an emergency use authorization for its COVID-19 vaccine to be given to adolescents.
Jun 10, 2021
0
0
The small archipelago nation of Seychelles, northeast of Madagascar in the Indian Ocean, has emerged as the world's most vaccinated country for COVID-19.
May 19, 2021
0
6
The coronavirus strain first linked to the COVID epidemic in India has now spread to at least 44 countries and been classified as a "variant of concern", but health authorities still know relatively little about it.
May 14, 2021
0
9
Moderna said Thursday its COVID-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.
May 6, 2021
0
9
